NOVEMBER 20235TECH OUTLOOKCXO INSIGHTSCXO INSIGHTSC O NT E NT SComplexities in the Development Process for Pharmaceutical ManufacturingErik Lemay,Head of Global External Manufacturing,Servier18Accelerating Drug Development of Novel Targeted Therapies through Histology-Agnostic Oncology Clinical TrialsHua Gong,SVP,Global Head of Translational Medicine and Clinical Biomarker,Zai Lab20The Next Challenge of Oncology Innovation:Meeting the Needs of ProvidersDana Edwards,Vice President,Patient Access and Strategic Engagement,UBC24Transforming Pharmacovigilance Using Technology ­ Help or Hype?Dr. Sebastian Horn,Vice President,Head of Global Patient Safety & Pharmacovigilance,Teva Pharmaceuticals26WHY STRAIN TYPING SHOULD BE IN YOUR MICROBIAL CONTROL TOOLBOXJon Kallay, Senior Technology and Market Development Manager, Charles River Laboratories28Featured CompanySciCordDavid Strauss,CEO16Technological advancements for industrial revolution 4.0Alessandro Gazzotti,Operations Director,Bormioli Pharma22TOP 10LIMSCONTRACTMANUFACTURING ORGANIZATIONS - 2023SOLUTIONS PROVIDERS - 2023
< Page 4 | Page 6 >